Published in Neurology on October 19, 2011
Myasthenia gravis: an update for the clinician. Clin Exp Immunol (2014) 1.45
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A (2013) 1.02
Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. J Physiol (2013) 1.00
Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol (2012) 0.98
Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nat Rev Neurol (2016) 0.93
Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis. J Autoimmun (2013) 0.89
COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina. Hum Genet (2013) 0.84
Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction. J Physiol (2014) 0.81
Animal models of antimuscle-specific kinase myasthenia. Ann N Y Acad Sci (2012) 0.79
Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling. Sci Rep (2015) 0.78
Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity. J Clin Neurol (2014) 0.78
Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis. Chem Biol Interact (2012) 0.78
Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis. PLoS One (2014) 0.77
Why does acetylcholine exacerbate myasthenia caused by anti-MuSK antibodies? J Physiol (2013) 0.76
Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis. Physiol Rep (2015) 0.76
Endoscopic thymectomy: a neurologist's perspective. Ann Cardiothorac Surg (2016) 0.75
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis. PLoS One (2015) 0.75
Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. F1000Res (2016) 0.75
The potential role of cell surface complement regulators and circulating CD4+ CD25+ T-cells in the development of autoimmune myasthenia gravis. Electron Physician (2016) 0.75
Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders. Int J Mol Sci (2017) 0.75
Myasthenia gravis with antibodies to MuSK: another step toward solving mystery? Neurology (2011) 0.75
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell (1996) 3.81
The isolation of gamma globulin from blood-serum by rivanol. Acta Med Scand (1956) 3.36
Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell (2008) 3.29
LRP4 serves as a coreceptor of agrin. Neuron (2008) 2.98
To build a synapse: signaling pathways in neuromuscular junction assembly. Development (2010) 2.65
The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science (2006) 2.26
Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain (2003) 2.11
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol (2004) 1.89
Clinical aspects of MuSK antibody positive seronegative MG. Neurology (2003) 1.89
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A (1998) 1.85
Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology (2004) 1.54
Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol (1999) 1.50
The mammalian gene of acetylcholinesterase-associated collagen. J Biol Chem (1997) 1.44
Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol (1999) 1.33
Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann Neurol (2008) 1.23
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain (2006) 1.18
Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol (2005) 1.14
Induction of myasthenia by immunization against muscle-specific kinase. J Clin Invest (2006) 1.13
MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J Cell Biol (2004) 1.13
Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol (2010) 1.09
Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J Neuroimmunol (2006) 1.09
C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem (2003) 1.08
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve (2010) 1.05
Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice. J Physiol (2010) 1.01
Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol (2007) 0.96
Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1. J Neuroimmunol (2008) 0.96
Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia. Muscle Nerve (2010) 0.94
The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates. Am J Pathol (2009) 0.93
Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J Neuroimmunol (2006) 0.92
Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase. J Biol Chem (2003) 0.91
Differences in expression of acetylcholinesterase and collagen Q control the distribution and oligomerization of the collagen-tailed forms in fast and slow muscles. J Neurosci (1999) 0.91
MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity. Eur J Neurosci (2011) 0.90
ColQ controls postsynaptic differentiation at the neuromuscular junction. J Neurosci (2010) 0.90
Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis. Neuroscience (2006) 0.89
Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology (2005) 0.86
Adeno-associated viral vector-mediated gene therapy of ischemia-induced neuronal death. Methods Enzymol (2002) 0.81
Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science (1996) 15.88
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem (1996) 10.51
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J (1996) 5.14
Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science (1997) 4.62
Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55
Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem (1999) 3.55
Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol (1999) 3.43
Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem (1997) 3.12
Columns for visual features of objects in monkey inferotemporal cortex. Nature (1992) 2.93
Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology (1975) 2.89
Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. Science (1999) 2.84
A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet (1999) 2.83
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. J Physiol (1982) 2.80
Complications of pedicle screw fixation in reconstructive surgery of the cervical spine. Spine (Phila Pa 1976) (2000) 2.77
The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci U S A (1998) 2.76
Improvement in visual sensitivity by changes in local context: parallel studies in human observers and in V1 of alert monkeys. Neuron (1995) 2.74
A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol Cell (1999) 2.71
Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol (1984) 2.66
Electrical behaviour of the motoneurone membrane during intracellularly applied current steps. J Physiol (1965) 2.60
Role of Ahch in gonadal development and gametogenesis. Nat Genet (1998) 2.60
Choice behavior of rats in a concurrent-chains schedule: Amount and delay of reinforcement. J Exp Anal Behav (1982) 2.59
Determinations of the DNA sequence of the mreB gene and of the gene products of the mre region that function in formation of the rod shape of Escherichia coli cells. J Bacteriol (1988) 2.59
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron (1995) 2.55
Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil (1998) 2.53
Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 2.49
Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med (1989) 2.49
DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science (1984) 2.47
The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem (1999) 2.45
Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43
Episome-mediated Transfer of Drug Resistance in Enterobacteriaceae X. Restriction and Modification of Phages by fi R Factors. J Bacteriol (1966) 2.43
Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol (1990) 2.42
Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood (2001) 2.39
Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. AJR Am J Roentgenol (1998) 2.38
Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science (1973) 2.34
Fingerprint body myopathy, a newly recognized congenital muscle disease. Mayo Clin Proc (1972) 2.34
Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus. Mol Cell Biol (1989) 2.33
Synthesis of DNA during meiosis. Proc Natl Acad Sci U S A (1966) 2.33
Nanoscale nuclear magnetic resonance with a nitrogen-vacancy spin sensor. Science (2013) 2.33
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron (1996) 2.27
Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol (1997) 2.25
Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol (1998) 2.24
Long-lasting depression of parallel fiber-Purkinje cell transmission induced by conjunctive stimulation of parallel fibers and climbing fibers in the cerebellar cortex. Neurosci Lett (1982) 2.21
Phytochrome action in Oryza sativa L. 3. The separation of photoperceptive site and growing zone in coleoptiles, and auxin transport as effector system. Dev Growth Differ (1969) 2.19
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 2.18
Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A (1998) 2.17
Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology (2000) 2.15
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
Benefit of bilateral over single internal mammary artery grafts for multiple coronary artery bypass grafting. Circulation (2001) 2.15
beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem (1999) 2.13
Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum. Dig Liver Dis (2004) 2.13
X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain (1989) 2.10
Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke (1999) 2.10
Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem (1999) 2.10
Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J Immunol (1985) 2.09
Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis (2000) 2.07
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
A new treatment for toxic megacolon. Lancet (1998) 2.05
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05
Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. N Engl J Med (1991) 2.00
Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet (1990) 1.98
Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem (2001) 1.98
Cell lineage analysis in ascidian embryos by intracellular injection of a tracer enzyme. III. Up to the tissue restricted stage. Dev Biol (1987) 1.97
Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene (2006) 1.94
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A (1995) 1.92
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A (2001) 1.90
Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol (1989) 1.89
Neural design of the cerebellar motor control system. Brain Res (1972) 1.88
A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A (2001) 1.88
Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood (2001) 1.88
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol (2001) 1.87
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A (1998) 1.85
Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc (1977) 1.85
The immunobiology of muscle. Immunol Today (1994) 1.83
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A (1989) 1.82
Inclusion body myositis. Observations in 40 patients. Brain (1989) 1.82
Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ (2004) 1.81
Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.79
[The fecal flora of man. IV. Communication: Comparison of the newly developed method with the old conventional method for the analysis of intestinal flora (author's transl)]. Zentralbl Bakteriol Orig A (1976) 1.79
Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun (1997) 1.79
Regulation of human lung epithelial cell numbers by diesel exhaust particles. Eur Respir J (2006) 1.79
Inhibitory control of intracerebellar nuclei by the purkinje cell axons. Exp Brain Res (1970) 1.78
Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (1977) 1.78
AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology (2000) 1.77
Myasthenia gravis and myasthenic syndromes. Ann Neurol (1984) 1.77
Complete nucleotide sequence of the chloroplast genome from the green alga Chlorella vulgaris: the existence of genes possibly involved in chloroplast division. Proc Natl Acad Sci U S A (1997) 1.75
Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat (2000) 1.75
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol (1998) 1.75
Determination of fascicle length and pennation in a contracting human muscle in vivo. J Appl Physiol (1985) (1997) 1.73
Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain (1970) 1.72
The spectrum and diagnosis of acid maltase deficiency. Neurology (1973) 1.71
Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem (1996) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Cerebellar control of the vestibulo-ocular reflex--around the flocculus hypothesis. Annu Rev Neurosci (1982) 1.71
Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy. Biochem Biophys Res Commun (1991) 1.70